HANADA, K.; KOBAYASHI, K. Invariant natural killer T cell–based immunotherapy using alpha-galactosylceramide–pulsed CD14+ monocytes for advanced gallbladder cancer. European Journal of Case Reports in Internal Medicine, v. 13, n. 8, 13 Jul.2026.